Weekly Recap: Buybacks and Novo deal for ELF U.S. authorization

Siemens Healthineers AG (XETR:SHL) continued buybacks—89,988 shares Sept 14—20, part of 3,214,359 repurchased since June 1—and deepened commercial ties with Novo to promote its U.S.-authorized ELF blood test for assessing advanced fibrosis in MASLD/MASH patients.Previous Week RecapThis is an AI-gen…